Authors: Morteza Maleki

Published on: April 07, 2024

Impact Score: 7.6

Arxiv code: Arxiv:2404.05044

Summary

• What is new: Use of GPT-4 for automating clinical trial protocol authoring, significantly enhancing efficiency and accuracy.
• Why this is important: Inefficiencies and inaccuracies in clinical trial protocol development.
• What the research proposes: Integrating advanced AI (GPT-4) to streamline and improve the protocol development process.
• Results: Significant improvements in protocol authoring efficiency, accuracy, and customization.

Technical Details

Technological frameworks used: Generative AI, specifically GPT-4

Models used: GPT-4

Data used: Comprehensive drug and study level metadata

Potential Impact

Clinical research organizations, pharmaceutical companies, biotech firms

Want to implement this idea in a business?

We have generated a startup concept here: TrialGenAI.